PROCTOFOAM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Proctofoam, and when can generic versions of Proctofoam launch?
Proctofoam is a drug marketed by Mylan Speciality Lp and is included in one NDA.
The generic ingredient in PROCTOFOAM is hydrocortisone acetate; pramoxine hydrochloride. There are sixty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate; pramoxine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROCTOFOAM?
- What are the global sales for PROCTOFOAM?
- What is Average Wholesale Price for PROCTOFOAM?
Summary for PROCTOFOAM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for PROCTOFOAM |
| DailyMed Link: | PROCTOFOAM at DailyMed |
US Patents and Regulatory Information for PROCTOFOAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Speciality Lp | PROCTOFOAM HC | hydrocortisone acetate; pramoxine hydrochloride | AEROSOL, METERED;TOPICAL | 086195-001 | Approved Prior to Jan 1, 1982 | BX | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
